# Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)

> **NCT02776488** · PHASE2 · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Brain Injuries, Traumatic

## Interventions

- **DRUG:** Sodium Lactate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02776488
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09
- **Primary completion:** 2025-12
- **Final completion:** 2026-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The manufacturer of sodium lactate has stopped making the medication
- **Last updated:** 2021-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02776488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02776488, "Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02776488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*